Mortality related to bacteremic pneumonia remains high, and the role of sepsis in inflammation, pulmonary injury, and death remains unclear, mostly in leukopenic states. In the present study, the microbiology, histopathology, and host response to Streptococcus pneumoniae and Klebsiella pneumoniae infection were determined in an experimental model of bacteremia in immunocompetent and leukopenic mice. Leukocyte depletion by cyclophosphamide did not impair the early clearance of pneumococci from blood but facilitated growth in lungs. By contrast, klebsiellae rapidly grew in blood of leukopenic mice. These observations suggest that tissue-based phagocytes and circulating leukocytes, respectively, play prominent roles in S. pneumoniae and K. pneumoniae eradication. The kinetics of leukocyte recruitment in lungs during S. pneumoniae bacteremia suggested early strong inflammation in immunocompetent mice that is associated with tumor necrosis factor alpha release and histological disorders, including cell debris and surfactant in alveolar spaces. Leukocyte depletion further stimulated pulmonary capillary leakage both in S. pneumoniae and K. pneumoniae bacteremia, which seemed attributable to bacterial virulence factors. Nitric oxide production did not differ significantly among groups. Leukopenia and low platelet counts characterized the late stage of bacteremia for both strains, but only K. pneumoniae altered renal function. Understanding the pathogenesis of bacteremia will help establish beneficial therapies for both sepsis and pneumonia.Bacterial pneumonia is a leading cause of morbidity and mortality in both developed and developing countries, and Streptococcus pneumoniae remains the most common pathogen responsible for community-acquired pneumonia throughout the world. It has been reported that human pneumococcal pulmonary infection when complicated with bacteremia results in two to three fold-higher mortality rates (22). Our previous experimental studies pointed out a direct correlation between bacteremia and mortality in immunocompetent mice suffering from pneumococcal pneumonia (2, 3). In fact, hemodynamic and hemostatic changes and progressive multiple organ failure are the most frequently observed adverse effects of bacteremia in humans. Conversely, sepsis also accounts for as many as half of all cases of acute respiratory distress syndrome (ARDS) (14,17,37). Lung injury apparently occurs at the very onset of bacteremia, this organ often being the first to fail (37). However, the contribution of sepsis to lung injury in the context of bacteremic bacterial pneumonia remains unclear. In various pathological conditions (5,8,11,14,19,24,28,33,39), lung injury induced by bacteremia is characterized by increased microvascular permeability and edema; hence, pathophysiological changes in the alveolar-capillary barrier most likely contribute to mortality resulting from bacteremia.A comparison of bacteremic community-acquired lobar pneumonia due to S. pneumoniae and Klebsiella pneumoniae in an intensive care unit alread...